Loading…

The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics

BACKGROUND: Erenumab has demonstrated effectiveness for prevention of migraine attacks, but the treatment is costly, and a considerable proportion of patients do not respond to it. The Registry for Migraine study (REFORM) was initiated to discover biomarkers that can predict response to erenumab in...

Full description

Bibliographic Details
Main Authors: Karlsson, William Kristian, Ashina, Håkan, Cullum, Christopher Kjær, Christensen, Rune Häckert, Al-Khazali, Haidar Muhsen, Amin, Faisal Mohammad, Ashina, Messoud
Format: Online Article Text
Language:English
Published: Springer Milan 2023
Subjects:
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257973/
https://www.ncbi.nlm.nih.gov/pubmed/37303034
http://dx.doi.org/10.1186/s10194-023-01604-2